Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The transdermal contraceptive system.

Ronald T Burkman1

  • 1Department of Obstetrics/Gynecology, Baystate Medical Center, Springfield, MA 01199, USA. rtb@bhs.org

American Journal of Obstetrics and Gynecology
|April 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Evolving Role of Midwives as Laborists.

Journal of midwifery & women's health·2015
Same author

Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.

Breast cancer research : BCR·2013
Same author

Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.

BMC cancer·2013
Same author

Estrogen-related genes and their contribution to racial differences in breast cancer risk.

Cancer causes & control : CCC·2012
Same author

Oral contraceptive formulation and risk of breast cancer.

Contraception·2011
Same author

Fifty years of "the pill": risk reduction and discovery of benefits beyond contraception, reflections, and forecast.

Toxicological sciences : an official journal of the Society of Toxicology·2011

The new contraceptive patch offers comparable safety and efficacy to oral contraceptives, with improved adherence due to its convenient weekly application. This transdermal system enhances hormone delivery and patient compliance.

Area of Science:

  • Reproductive Health
  • Pharmacology
  • Dermatology

Background:

  • The contraceptive patch is a novel hormonal contraceptive delivering norelgestromin and ethinyl estradiol.
  • Approved in 2001, it offers an alternative to traditional oral contraceptives.
  • Transdermal delivery bypasses hepatic first-pass metabolism, potentially improving hormone level stability.

Purpose of the Study:

  • To evaluate the safety and efficacy of the transdermal contraceptive system.
  • To compare patient compliance between the transdermal patch and oral contraceptives.
  • To assess the pharmacokinetic advantages of transdermal delivery.

Main Methods:

  • Clinical trials were conducted to assess safety and efficacy.
  • Patient compliance was monitored in women using the patch versus oral contraceptives.

Related Experiment Videos

  • Pharmacokinetic profiles were analyzed, comparing transdermal delivery to oral administration.

    • Main Results:

    • The contraceptive patch demonstrated comparable safety and efficacy to oral contraceptives.
    • Women using the patch showed higher correct and consistent usage rates.
    • Transdermal delivery resulted in minimized hormone concentration fluctuations and avoided first-pass metabolism.

    Conclusions:

    • The transdermal contraceptive system provides a safe and effective birth control option.
    • Weekly application of the patch enhances patient compliance and ease of use.
    • Transdermal delivery offers potential pharmacokinetic benefits over daily oral contraceptives.